Immunovant

IMVT

IMVT Immunovant NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    IMVT Chart
    See on advanced chart >

    About

    Immunovant, Inc.was incorporated in Delaware on December 6, 2018.The company is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
    • Highlight
      A clinical-stage biopharmaceutical company that developing therapies for autoimmune diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/21/2019
    • Established Date
      12/06/2018
    • Full-time Employees
      164
    • Address
      320 West 37th Street New York NY 10018
    • Tel
      1-917-5803099
    • Website
    • Fiscal Year End Date
      03/31
    • Security Type
      Common Stock
    cache time: 2024-04-17 08:14:17